The Coronavirus Disease 2019 pandemic: how does it spread and how do we stop it?
Identifieur interne : 000057 ( Main/Exploration ); précédent : 000056; suivant : 000058The Coronavirus Disease 2019 pandemic: how does it spread and how do we stop it?
Auteurs : Xin Li ; Siddharth Sridhar ; Jasper Fuk-Woo Chan [République populaire de Chine]Source :
- Current opinion in HIV and AIDS [ 1746-6318 ] ; 2020.
Descripteurs français
- KwdFr :
- Betacoronavirus (MeSH), Humains (MeSH), Infections à coronavirus (immunologie), Infections à coronavirus (prévention et contrôle), Infections à coronavirus (transmission), Pandémies (prévention et contrôle), Pneumopathie virale (prévention et contrôle), Pneumopathie virale (transmission), Vaccins antiviraux (immunologie).
- MESH :
- immunologie : Infections à coronavirus, Vaccins antiviraux.
- prévention et contrôle : Infections à coronavirus, Pandémies, Pneumopathie virale.
- transmission : Betacoronavirus, Humains, Infections à coronavirus, Pneumopathie virale.
English descriptors
- KwdEn :
- Betacoronavirus (MeSH), COVID-19 (MeSH), COVID-19 Vaccines (MeSH), Coronavirus Infections (immunology), Coronavirus Infections (prevention & control), Coronavirus Infections (transmission), Humans (MeSH), Pandemics (prevention & control), Pneumonia, Viral (prevention & control), Pneumonia, Viral (transmission), SARS-CoV-2 (MeSH), Viral Vaccines (immunology).
- MESH :
- chemical , immunology : Viral Vaccines.
- chemical : COVID-19 Vaccines.
- immunology : Coronavirus Infections.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- Betacoronavirus, COVID-19, Humans, SARS-CoV-2.
Abstract
PURPOSE OF REVIEW
The Coronavirus Disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health threat associated with major socioeconomic disruptions. Understanding on the transmission characteristics of SARS-CoV-2 is crucial for optimizing preventive strategies.
RECENT FINDINGS
SARS-CoV-2 can be transmitted efficiently between persons through respiratory droplets and direct and indirect contact. The significance of airborne droplet nuclei in SARS-CoV-2 transmission in the community setting is less clear. SARS-CoV-2 RNA and live viral particles may also be detected in other bodily fluids. Outbreaks have been reported in families, nursing homes, markets, restaurants, churches, shipping vessels, gyms, and healthcare facilities. Nonpharmaceutical preventive measures at both the community and individual levels are essential for reducing the transmission of SARS-CoV-2.
SUMMARY
Because well tolerated and effective vaccines for SARS-CoV-2 are unlikely to be widely available in the near future, there is an urgent need for finding other measures to reduce the spread of the COVID-19 pandemic. With better understanding of its transmission characteristics, practical nonpharmaceutical preventive measures remain essential to reduce SARS-CoV-2 transmission and its associated health and socioeconomic burdens.
DOI: 10.1097/COH.0000000000000650
PubMed: 32969975
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Coronavirus Disease 2019 pandemic: how does it spread and how do we stop it?</title><author><name sortKey="Li, Xin" sort="Li, Xin" uniqKey="Li X" first="Xin" last="Li">Xin Li</name><affiliation><nlm:affiliation>Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region.</nlm:affiliation><wicri:noCountry code="subField">Hong Kong Special Administrative Region</wicri:noCountry></affiliation></author><author><name sortKey="Sridhar, Siddharth" sort="Sridhar, Siddharth" uniqKey="Sridhar S" first="Siddharth" last="Sridhar">Siddharth Sridhar</name><affiliation><nlm:affiliation>Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong Province.</nlm:affiliation><wicri:noCountry code="subField">Guangdong Province</wicri:noCountry></affiliation><affiliation><nlm:affiliation>State Key Laboratory of Emerging Infectious Diseases.</nlm:affiliation><wicri:noCountry code="no comma">State Key Laboratory of Emerging Infectious Diseases.</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine.</nlm:affiliation><wicri:noCountry code="subField">Li Ka Shing Faculty of Medicine</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Carol Yu Centre for Infection.</nlm:affiliation><wicri:noCountry code="no comma">Carol Yu Centre for Infection.</wicri:noCountry></affiliation></author><author><name sortKey="Chan, Jasper Fuk Woo" sort="Chan, Jasper Fuk Woo" uniqKey="Chan J" first="Jasper Fuk-Woo" last="Chan">Jasper Fuk-Woo Chan</name><affiliation><nlm:affiliation>Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong Province.</nlm:affiliation><wicri:noCountry code="subField">Guangdong Province</wicri:noCountry></affiliation><affiliation><nlm:affiliation>State Key Laboratory of Emerging Infectious Diseases.</nlm:affiliation><wicri:noCountry code="no comma">State Key Laboratory of Emerging Infectious Diseases.</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine.</nlm:affiliation><wicri:noCountry code="subField">Li Ka Shing Faculty of Medicine</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Carol Yu Centre for Infection.</nlm:affiliation><wicri:noCountry code="no comma">Carol Yu Centre for Infection.</wicri:noCountry></affiliation><affiliation wicri:level="1"><nlm:affiliation>Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region</wicri:regionArea><wicri:noRegion>Hong Kong Special Administrative Region</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32969975</idno><idno type="pmid">32969975</idno><idno type="doi">10.1097/COH.0000000000000650</idno><idno type="wicri:Area/Main/Corpus">000101</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000101</idno><idno type="wicri:Area/Main/Curation">000101</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000101</idno><idno type="wicri:Area/Main/Exploration">000101</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The Coronavirus Disease 2019 pandemic: how does it spread and how do we stop it?</title><author><name sortKey="Li, Xin" sort="Li, Xin" uniqKey="Li X" first="Xin" last="Li">Xin Li</name><affiliation><nlm:affiliation>Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region.</nlm:affiliation><wicri:noCountry code="subField">Hong Kong Special Administrative Region</wicri:noCountry></affiliation></author><author><name sortKey="Sridhar, Siddharth" sort="Sridhar, Siddharth" uniqKey="Sridhar S" first="Siddharth" last="Sridhar">Siddharth Sridhar</name><affiliation><nlm:affiliation>Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong Province.</nlm:affiliation><wicri:noCountry code="subField">Guangdong Province</wicri:noCountry></affiliation><affiliation><nlm:affiliation>State Key Laboratory of Emerging Infectious Diseases.</nlm:affiliation><wicri:noCountry code="no comma">State Key Laboratory of Emerging Infectious Diseases.</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine.</nlm:affiliation><wicri:noCountry code="subField">Li Ka Shing Faculty of Medicine</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Carol Yu Centre for Infection.</nlm:affiliation><wicri:noCountry code="no comma">Carol Yu Centre for Infection.</wicri:noCountry></affiliation></author><author><name sortKey="Chan, Jasper Fuk Woo" sort="Chan, Jasper Fuk Woo" uniqKey="Chan J" first="Jasper Fuk-Woo" last="Chan">Jasper Fuk-Woo Chan</name><affiliation><nlm:affiliation>Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong Province.</nlm:affiliation><wicri:noCountry code="subField">Guangdong Province</wicri:noCountry></affiliation><affiliation><nlm:affiliation>State Key Laboratory of Emerging Infectious Diseases.</nlm:affiliation><wicri:noCountry code="no comma">State Key Laboratory of Emerging Infectious Diseases.</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine.</nlm:affiliation><wicri:noCountry code="subField">Li Ka Shing Faculty of Medicine</wicri:noCountry></affiliation><affiliation><nlm:affiliation>Carol Yu Centre for Infection.</nlm:affiliation><wicri:noCountry code="no comma">Carol Yu Centre for Infection.</wicri:noCountry></affiliation><affiliation wicri:level="1"><nlm:affiliation>Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region</wicri:regionArea><wicri:noRegion>Hong Kong Special Administrative Region</wicri:noRegion></affiliation></author></analytic><series><title level="j">Current opinion in HIV and AIDS</title><idno type="eISSN">1746-6318</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>COVID-19 Vaccines (MeSH)</term><term>Coronavirus Infections (immunology)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (transmission)</term><term>Humans (MeSH)</term><term>Pandemics (prevention & control)</term><term>Pneumonia, Viral (prevention & control)</term><term>Pneumonia, Viral (transmission)</term><term>SARS-CoV-2 (MeSH)</term><term>Viral Vaccines (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (MeSH)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (immunologie)</term><term>Infections à coronavirus (prévention et contrôle)</term><term>Infections à coronavirus (transmission)</term><term>Pandémies (prévention et contrôle)</term><term>Pneumopathie virale (prévention et contrôle)</term><term>Pneumopathie virale (transmission)</term><term>Vaccins antiviraux (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>COVID-19 Vaccines</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Humans</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="fr"><term>Betacoronavirus</term><term>Humains</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>PURPOSE OF REVIEW</b></p><p>The Coronavirus Disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health threat associated with major socioeconomic disruptions. Understanding on the transmission characteristics of SARS-CoV-2 is crucial for optimizing preventive strategies.</p></div><div type="abstract" xml:lang="en"><p><b>RECENT FINDINGS</b></p><p>SARS-CoV-2 can be transmitted efficiently between persons through respiratory droplets and direct and indirect contact. The significance of airborne droplet nuclei in SARS-CoV-2 transmission in the community setting is less clear. SARS-CoV-2 RNA and live viral particles may also be detected in other bodily fluids. Outbreaks have been reported in families, nursing homes, markets, restaurants, churches, shipping vessels, gyms, and healthcare facilities. Nonpharmaceutical preventive measures at both the community and individual levels are essential for reducing the transmission of SARS-CoV-2.</p></div><div type="abstract" xml:lang="en"><p><b>SUMMARY</b></p><p>Because well tolerated and effective vaccines for SARS-CoV-2 are unlikely to be widely available in the near future, there is an urgent need for finding other measures to reduce the spread of the COVID-19 pandemic. With better understanding of its transmission characteristics, practical nonpharmaceutical preventive measures remain essential to reduce SARS-CoV-2 transmission and its associated health and socioeconomic burdens.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32969975</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1746-6318</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>11</Month></PubDate></JournalIssue><Title>Current opinion in HIV and AIDS</Title><ISOAbbreviation>Curr Opin HIV AIDS</ISOAbbreviation></Journal><ArticleTitle>The Coronavirus Disease 2019 pandemic: how does it spread and how do we stop it?</ArticleTitle><Pagination><MedlinePgn>328-335</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/COH.0000000000000650</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">The Coronavirus Disease 2019 (COVID-19) pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health threat associated with major socioeconomic disruptions. Understanding on the transmission characteristics of SARS-CoV-2 is crucial for optimizing preventive strategies.</AbstractText><AbstractText Label="RECENT FINDINGS">SARS-CoV-2 can be transmitted efficiently between persons through respiratory droplets and direct and indirect contact. The significance of airborne droplet nuclei in SARS-CoV-2 transmission in the community setting is less clear. SARS-CoV-2 RNA and live viral particles may also be detected in other bodily fluids. Outbreaks have been reported in families, nursing homes, markets, restaurants, churches, shipping vessels, gyms, and healthcare facilities. Nonpharmaceutical preventive measures at both the community and individual levels are essential for reducing the transmission of SARS-CoV-2.</AbstractText><AbstractText Label="SUMMARY">Because well tolerated and effective vaccines for SARS-CoV-2 are unlikely to be widely available in the near future, there is an urgent need for finding other measures to reduce the spread of the COVID-19 pandemic. With better understanding of its transmission characteristics, practical nonpharmaceutical preventive measures remain essential to reduce SARS-CoV-2 transmission and its associated health and socioeconomic burdens.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sridhar</LastName><ForeName>Siddharth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong Province.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Carol Yu Centre for Infection.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Jasper Fuk-Woo</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong Province.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Emerging Infectious Diseases.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Li Ka Shing Faculty of Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Carol Yu Centre for Infection.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hainan Medical University-The University of Hong Kong Joint Laboratory of Tropical Infectious Diseases, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Opin HIV AIDS</MedlineTA><NlmUniqueID>101264945</NlmUniqueID><ISSNLinking>1746-630X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CitationSubset>X</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>24</Day><Hour>12</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32969975</ArticleId><ArticleId IdType="doi">10.1097/COH.0000000000000650</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><noCountry><name sortKey="Li, Xin" sort="Li, Xin" uniqKey="Li X" first="Xin" last="Li">Xin Li</name><name sortKey="Sridhar, Siddharth" sort="Sridhar, Siddharth" uniqKey="Sridhar S" first="Siddharth" last="Sridhar">Siddharth Sridhar</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Chan, Jasper Fuk Woo" sort="Chan, Jasper Fuk Woo" uniqKey="Chan J" first="Jasper Fuk-Woo" last="Chan">Jasper Fuk-Woo Chan</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Wicri/explor/CovidPublicV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000057 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000057 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Wicri
|area= CovidPublicV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32969975
|texte= The Coronavirus Disease 2019 pandemic: how does it spread and how do we stop it?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32969975" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidPublicV1
| This area was generated with Dilib version V0.6.38. |  |